Stockscreener 앱 받기
0.6029
22.82%
0.112
전일 마감가:
$0.4909
열려 있는:
$0.5
하루 거래량:
7.66M
Relative Volume:
3.42
시가총액:
$85.36M
수익:
-
순이익/손실:
$-119.76M
주가수익비율:
-0.4466
EPS:
-1.35
순현금흐름:
$-55.17M
1주 성능:
+50.84%
1개월 성능:
+98.45%
6개월 성능:
-93.06%
1년 성능:
-85.81%
1일 변동 폭
$0.491
$0.638
1주일 범위
$0.4151
$0.638
52주 변동 폭
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
명칭
Applied Therapeutics Inc
전화
212-220-9226
주소
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.6029 | 56.59M | 0 | -119.76M | -55.17M | -1.35 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-23 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | 개시 | William Blair | Outperform |
| 2024-03-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-22 | 개시 | Leerink Partners | Outperform |
| 2022-01-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-08-27 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-06-25 | 재개 | Goldman | Neutral |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-04-22 | 개시 | Goldman | Buy |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2019-06-10 | 개시 | Citigroup | Buy |
| 2019-06-10 | 개시 | Cowen | Outperform |
| 2019-06-10 | 개시 | Robert W. Baird | Outperform |
모두보기
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Applied Therapeutics Presents Full 12-Month Clinical Results and - GuruFocus
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewswire
Breakthrough in CMT Treatment: New Clinical Data Shows First-Ever Disease Progression Slowing in 24-Month Study - Stock Titan
Massive News for Apple Stock Investors! - The Globe and Mail
APLT: RBC Capital Reiterates Sector Perform Rating, Price Target Maintained | APLT Stock News - GuruFocus
Applied Therapeutics Reports First Quarter 2025 Financial Results | APLT Stock News - GuruFocus
Applied Therapeutics, Inc. SEC 10-Q Report - TradingView
Barclays PLC Sells 27,997 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
APLT Reports Financial Position and Advances in Govorestat Resea - GuruFocus
Applied Therapeutics Reports First Quarter 2025 Financial Results - Bluefield Daily Telegraph
Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.
APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Alyeska Investment Group L.P. Boosts Stock Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky about Pending Class ActionAPLT - ACCESS Newswire
Applied Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationAPLT - ACCESS Newswire
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your RightsAPLT - ACCESS Newswire
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Investors who lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class ActionAPLT - ACCESS Newswire
Shareholders that Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire
Applied Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025APLT - ACCESS Newswire
Shareholders That Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire
Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire
Applied Therapeutics Announces Acceptance of Late-Breaking Abstr - GuruFocus
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – APLT - ACCESS Newswire
APLT's Govorestat Phase 3 Trial Results to be Presented at 2025 Conference | APLT Stock News - GuruFocus
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewswire
APLT stock touches 52-week low at $0.54 amid market challenges - MSN
Schonfeld Strategic Advisors LLC Acquires 8,419,781 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Applied Therapeutics (APLT) to Release Earnings on Thursday - Defense World
Applied Therapeutics, Inc. (NASDAQ:APLT) Stock Position Increased by Marshall Wace LLP - MarketBeat
Invesco Ltd. Sells 506,118 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Applied Therapeutics (APLT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Adage Capital Partners GP L.L.C. Cuts Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Applied Therapeutics, Inc. (NASDAQ:APLT) Holdings Lifted by T. Rowe Price Investment Management Inc. - MarketBeat
Applied Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire
Legal & General Group Plc Boosts Stock Position in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Propel Bio Management LLC Acquires 3,047,562 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Long-Term Investors who hold shares of Applied Therapeutics, - openPR.com
Applied Therapeutics Inc (APLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Applied Therapeutics Inc 주식 (APLT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
| Funtleyder Leslie D. | Chief Financial Officer |
Aug 22 '24 |
Sale |
5.83 |
13,530 |
78,880 |
277,911 |
| Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
| Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
| Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
| Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
1.54%
7.58%
자본화:
|
볼륨(24시간):